4.4 Review

Costs and cost-effectiveness of malaria control interventions - a systematic review

期刊

MALARIA JOURNAL
卷 10, 期 -, 页码 -

出版社

BMC
DOI: 10.1186/1475-2875-10-337

关键词

-

资金

  1. Bill and Melinda Gates Foundation Vaccine Modelling Initiative
  2. Medical Research Council
  3. Global Fund
  4. MRC [G0600719] Funding Source: UKRI
  5. Medical Research Council [G0600719, G0600719B] Funding Source: researchfish

向作者/读者索取更多资源

Background: The control and elimination of malaria requires expanded coverage of and access to effective malaria control interventions such as insecticide-treated nets (ITNs), indoor residual spraying (IRS), intermittent preventive treatment (IPT), diagnostic testing and appropriate treatment. Decisions on how to scale up the coverage of these interventions need to be based on evidence of programme effectiveness, equity and cost-effectiveness. Methods: A systematic review of the published literature on the costs and cost-effectiveness of malaria interventions was undertaken. All costs and cost-effectiveness ratios were inflated to 2009 USD to allow comparison of the costs and benefits of several different interventions through various delivery channels, across different geographical regions and from varying costing perspectives. Results: Fifty-five studies of the costs and forty three studies of the cost-effectiveness of malaria interventions were identified, 78% of which were undertaken in sub-Saharan Africa, 18% in Asia and 4% in South America. The median financial cost of protecting one person for one year was $2.20 (range $0.88-$9.54) for ITNs, $6.70 (range $2.22$12.85) for IRS, $0.60 (range $0.48-$1.08) for IPT in infants, $4.03 (range $1.25-$11.80) for IPT in children, and $2.06 (range $0.47-$3.36) for IPT in pregnant women. The median financial cost of diagnosing a case of malaria was $4.32 (range $0.34-$9.34). The median financial cost of treating an episode of uncomplicated malaria was $5.84 (range $2.36-$23.65) and the median financial cost of treating an episode of severe malaria was $30.26 (range $15.64-$137.87). Economies of scale were observed in the implementation of ITNs, IRS and IPT, with lower unit costs reported in studies with larger numbers of beneficiaries. From a provider perspective, the median incremental cost effectiveness ratio per disability adjusted life year averted was $27 (range $8.15-$110) for ITNs, $143 (range $135-$150) for IRS, and $24 (range $1.08-$44.24) for IPT. Conclusions: A transparent evidence base on the costs and cost-effectiveness of malaria control interventions is provided to inform rational resource allocation by donors and domestic health budgets and the selection of optimal packages of interventions by malaria control programmes.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Health Care Sciences & Services

National responses to global health targets: exploring policy transfer in the context of the UNAIDS '90-90-90' treatment targets in Ghana and Uganda

Ellen McRobie, Fred Matovu, Aisha Nanyiti, Justice Nonvignon, Daniel Nana Yaw Abankwah, Kelsey K. Case, Timothy B. Hallett, Johanna Hanefeld, Lesong Conteh

HEALTH POLICY AND PLANNING (2018)

Article Immunology

Community-based Malaria Screening and Treatment for Pregnant Women Receiving Standard Intermittent Preventive Treatment With Sulfadoxine-Pyrimethamine: A Multicenter (The Gambia, Burkina Faso, and Benin) Cluster-randomized Controlled Trial

Susana Scott, Umberto D'Alessandro, Lindsay Kendall, John Bradley, Kalifa Bojang, Simon Correa, Fanta Njie, Halidou Tinto, Maminata Traore-Coulibaly, Hamtandi Magloire Natama, Ousmane Traore, Innocent Valea, Alain Nahum, Daniel Ahounou, Francis Bohissou, Gethaime Sondjo, Carine Agbowai, Petra Mens, Esmee Ruizendaal, Henk Schallig, Susan Dierickx, Koen Peeters Grietens, Laetitia Duval, Lesong Conteh, Maxime Drabo, Jamie Guth, Franco Pagnoni

CLINICAL INFECTIOUS DISEASES (2019)

Article Infectious Diseases

Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses

Michael T. White, Stephan Karl, Cristian Koepfli, Rhea J. Longley, Natalie E. Hofmann, Rahel Wampfler, Ingrid Felger, Tom Smith, Wang Nguitragool, Jetsumon Sattabongkot, Leanne Robinson, Azra Ghani, Ivo Mueller

MALARIA JOURNAL (2018)

Article Infectious Diseases

Plasmodium falciparum genetic variation of var2csa in the Democratic Republic of the Congo

Robert Verity, Nicholas J. Hathaway, Andreea Waltmann, Stephanie M. Doctor, Oliver J. Watson, Jaymin C. Patel, Kashamuka Mwandagalirwa, Antoinette K. Tshefu, Jeffrey A. Bailey, Azra C. Ghani, Jonathan J. Juliano, Steven R. Meshnick

MALARIA JOURNAL (2018)

Article Multidisciplinary Sciences

Estimating spatiotemporally varying malaria reproduction numbers in a near elimination setting

Isobel Routledge, Jose Eduardo Romero Cheyez, Zulma M. Cucunuba, Manuel Gomez Rodriguez, Caterina Guinovart, Kyle B. Gustafson, Kammerle Schneider, Patrick Gt Walker, Azra C. Ghani, Samir Bhatt

NATURE COMMUNICATIONS (2018)

Article Multidisciplinary Sciences

Mathematical models of human mobility of relevance to malaria transmission in Africa

John M. Marshall, Sean L. Wu, Hector M. C. Sanchez, Samson S. Kiware, Micky Ndhlovu, Andre Lin Ouedraogo, Mahamoudou B. Toure, Hugh J. Sturrock, Azra C. Ghani, Neil M. Ferguson

SCIENTIFIC REPORTS (2018)

Article Biology

Synergy in anti malarial pre-erythrocytic and transmission-blocking antibodies is achieved by reducing parasite density

Ellie Sherrard-Smith, Katarzyna A. Sala, Michael Betancourt, Leanna M. Upton, Fiona Angrisano, Merribeth J. Morin, Azra C. Ghani, Thomas S. Churcher, Andrew M. Blagborough

Article Multidisciplinary Sciences

Mathematical modelling of the impact of expanding levels of malaria control interventions on Plasmodium vivax

Michael T. White, Patrick Walker, Stephan Karl, Manuel W. Hetzel, Tim Freeman, Andreea Waltmann, Moses Laman, Leanne J. Robinson, Azra Ghani, Ivo Mueller

NATURE COMMUNICATIONS (2018)

Editorial Material Biology

Age, exposure and immunity

Michael White, James Watson

Article Infectious Diseases

Cost-effectiveness of district-wide seasonal malaria chemoprevention when implemented through routine malaria control programme in Kita, Mali using fixed point distribution

Halimatou Diawara, Patrick Walker, Matt Cairns, Laura C. Steinhardt, Fatou Diawara, Beh Kamate, Laeticia Duval, Elisa Sicuri, Issaka Sagara, Aboubacar Sadou, Jules Mihigo, Erin Eckert, Alassane Dicko, Lesong Conteh

Summary: Seasonal malaria chemoprevention (SMC) is a strategy recommended by the WHO for malaria control since 2012, and Mali implemented nationwide scale-up through a pilot plan in 2016. The study found that SMC implemented through routine health system in Mali was highly cost-effective, with financial incentives being a major cost component as seen in previous studies.

MALARIA JOURNAL (2021)

Review Economics

Costs and Cost-Effectiveness of Malaria Control Interventions: A Systematic Literature Review

Lesong Conteh, Kathryn Shuford, Efundem Agboraw, Mara Kont, Jan Kolaczinski, Edith Patouillard

Summary: The study reviewed 103 costing studies on the unit cost and cost-effectiveness of malaria control from 2005 to 2018, finding that the cost varied significantly depending on the interventions, provider perspective, and country. While cost-effectiveness of malaria control was emphasized in many studies, there was a lack of data transferability due to variability in methods and reporting standards.

VALUE IN HEALTH (2021)

Article Environmental Sciences

Improved housing versus usual practice for additional protection against clinical malaria in The Gambia (RooPfs): a household-randomised controlled trial

Margaret Pinder, John Bradley, Musa Jawara, Muna Affara, Lesong Conteh, Simon Correa, David Jeffries, Caroline Jones, Balla Kandeh, Jakob Knudsen, Yekini Olatunji, Elisa Sicuri, Umberto D'Alessandro, Steve W. Lindsay

Summary: In a study conducted in The Gambia, improved housing did not provide protection against clinical malaria. Despite high coverage of insecticide-treated nets, indoor residual spraying, and seasonal malaria chemoprevention, no significant effect was observed in an area with low seasonal transmission.

LANCET PLANETARY HEALTH (2021)

Review Oncology

Breast Cancer Disparities Among Women in Low- and Middle-Income Countries

O. Ginsburg, A. F. Rositch, L. Conteh, M. Mutebi, E. D. Paskett, S. Subramanian

CURRENT BREAST CANCER REPORTS (2018)

暂无数据